Heart health

Triglycerides ↓; heart events

Plaque/BP/vascular function

Homocysteine ↓, cardiac risk

Vascular function ↑, Hcy ↓

Lipids↓ TG,LDL

Arrhythmia/Death↓ AF,MACE

K↓ arrhythmia risk

K↑ arrhythmia risk

LDL/TC↓ 8-14%

BP↓ 6-10 mmHg

Lower homocysteine

Better vessel function

Lower stroke risk

LDL↓, HDL↑

Vessel function↑, oxidation↓

BP↓, events↓

Triglycerides, BP -5 mmHg

AF recurrence 38.5% vs 77.5%

Vascular function, plaque slower

Arrhythmia prevention

-23 p.p. AF

Blood pressure lower

BP/endothelium

-7.5 mmHg

Lipids/inflammation

Better heart calcification

Warfarin INR control

Lipids ↓, BP ↓

Events ↓, death ↓

Inflammation ↓, vessels ↑

Heart rhythm/QT improved

BP/AF changes with calcium

Hcy↓, vessel function↑

Hcy↓, plaque/events↓

LDL/TC ↓ 7–23%

ApoB/oxidized LDL ↓

TG/HDL markers ↓

LDL↓, TG−16.6%

Heart injury↓, stays−1d

Vasodilation↑, BP↓

HDL↑ LDL↓ events↓

IMT↓ 0.01mm

Cardio mortality -49%

Heart function, biomarkers

Cholesterol reduced ~12%

Innervation +7% vs -14%

Exercise/ischaemia +45s, +25%

Mortality -11.3%

Lower TMAO/homocysteine

Better vessel function

Fewer MI/stroke

Heart injury/function: ↓ injury

Rhythm/autonomic: ↓ arrhythmias

Pump function, fewer events

BP, inflammation, oxidative stress

Blood pressure, lipids

Platelets, plaques

LDL/TC ↓, BP ↓

Endothelial function ↑

Inflammation/oxidation ↓

Lipid lowering, HDL↑

Plaque/heart risk ↓

Lipids/endothelial health

+37% FMD, -58 mg/dL TG

Glucose/BP/inflammation

Angina relief, +25pp

Endothelial/arterial function, -46%

Lower heart injury markers, -26%

Lipids/HDL +7.7–37.5%

Blood pressure/FMD ↓

Inflammation/oxidation ↓

Endothelial function +50%

LDL/BP −12 mmHg

LDL/TC -20-35%

Events/death -30-50%

Function/inflammation improved

Lower BP, fewer events

Homocysteine down, lipids up

↓ ischemia/angina, +14% TIMI

↓ AF/inflammation/oxidative stress

LDL −30%; total −10%

BP −6 mmHg

Lipids: LDL↓ HDL↑

Platelets/BP: less clotting

LDL/TC ↓

Inflammation/arterial function ↓

Lipids/BP ↓

Inflammation/ischemia ↓

Lipids, glucose, BP

MI -16.9%; PWV

Endothelial function + FMD

BP/insulin/inflammation down

LDL ↓ 6-14%

Sterol markers ↑/↓

Lower LDL/TG

Better BP/FMD

Anti-clotting ↑EPA

Lipids down: LDL/TC

Blood pressure/endothelial function up

Arrhythmia/ischemia reduced

Lower BP, stiffness

Event risk −10%

BP↓ / FMD↑

Arterial stiffness↓ / mPAP↓

Endothelial dilation +2.4%

Blood pressure -15 mmHg

LVEF up, symptoms better

+4.24% LVEF; biomarkers down

TMAO↑/↓ heart risk

Lipids, BP, restenosis ↓

Cholesterol/LDL down

Inflammation down

BP/FMD improved

Lower BP, better FMD

Less ischemic death

LDL, HbA1c ↓

BP/HR, CVD risk ↓

Lipids, −20% LDL

Blood pressure, −13.1 mmHg

Oxidative stress, −37.5% CRP

Lipids ↓; heart risk

BP/HRV improved; heart risk

Endothelial/oxidation improved

Homocysteine −24%

CVD risk HR≈2.2

Blood pressure −20 mmHg

Lipids/glucose improved

Lipids↓ TG/LDL

Blood sugar↓ FBG/HbA1c

BP/inflammation↓

Exercise capacity, symptoms

BP/cardiac workload, inflammation

Blood pressure, stiffness

Lipids, glucose, inflammation

BP & lipids improved

Heart function protected

Stool more frequent

Transit faster

Pump function +5.1% LVEF

Lipids/angina ↓; FMD +4.1

Endothelial function +FMD

Blood pressure/lipids ↓

Insulin resistance/lipids ↓

Better glucose control

Lipids/BP down

LDL/TG down

Inflammation/vascular markers improved

LDL/ApoB↓, HDL↑

BP control↑, bleeding↓

Heart risk factors down

TC/LDL/TG lower

+2.8 HDL

Lipids down; HDL up

Inflammation down; vascular up

Lipids/glucose ↓; HDL ↑

LDL -18 mg/dL

Lower LDL/total cholesterol

Better LDL:HDL ratio

LDL/TC ↓ ~10-22%

Triglycerides/BP ↓

Homocysteine ↓ 22-40%

BP ↓ 5-9 mmHg

Lower LDL, BP

HTN risk -34%

Lower TG, LDL

TG/LDL ↓ ~10%

Omega-3 ↑ 2x

Vessels: FMD↑, PWV↓

Lipids/Inflammation: LDL↓, CRP↓

LDL/total cholesterol ↓

Blood vessel function ↑

Triglycerides/insulin ↓

Endothelial health, +41%

Blood pressure, -7.5

Arterial compliance +23%

LDL/HDL improved

Blood pressure -8/-4

Lipids/oxidative stress

Glucose/endothelial

Vessel function: +28.4% FMD

Blood pressure: -6.9 mmHg

EF +7-8%

Inflammation -59%

Heart function +3.9%

Cardiac injury -61.5%

Pump function +5.3%

Diuresis, injury↓

Better heart pump

↓ inflammation, BP

Stiffer arteries -0.34 m/s

Lower CVD risk HR 0.80

Better lipids/BMI

Lipids↓, HDL↑

Inflammation↓

Lipids improve; DBP -4.8 mmHg

Cholesterol, triglycerides, HDL/ApoB

Cholesterol −4.7 to −6.4%

Systolic BP −5 mmHg

Lipid lowering

Platelet/endothelial support

Endothelial function, BP -6

Inflammation/lipids, FMD +28%

Lipids ↓; FMD ↑

BP/stiffness ↓; eNOS ↑

Blood pressure ↓ 8.8

Atherogenic lipids ↓ 18%

Vascular/inflammation +21%

Lipids/cholesterol -23%

Inflammation/enzymes -19%

LDL down ~10%

HDL up, glucose down

Small LDL reduced

Blood pressure ↓

Endothelial function ↑

Vessel function +1.6%

Lower CVD risk 52%

VAT loss −14.1%

Lower BP, TG

Less stiffness, IL-8

BP -7.6 mmHg

LDL/triglycerides down

Blood pressure -10/6

Lipids/glucose/inflammation lower

Arteries/events improved

BP, TG, CRP -10/-14

LDL, glucose, HbA1c -22%

Endothelial function +0.31

Nitric oxide, spermidine

Omega-3↑; triglycerides↓

HDL↑ 7%; TG↓

Platelet aggregation↓; cholesterol↔

Memory + BP

-7 mmHg SBP

Faster executive response

Weight/waist, HDL↑

Glucose/lipids improved

Clotting slowed; PT/aPTT↑

BP lowered; renin↓ (-5.6/-2.8)

Oxidative stress ↓

Lipids improved −22%

Lipids improved heart markers

HDL/LDL +32%

Cholesterol, TG down

Weight/waist −5.2 kg

Lipids improved; TG −42%

BP ↓; LDL/TC ↓

VO2max, SV/CO ↑

-14% LDL, +10% TC

Heart rate -4%

IL-6 -

LDL -28.3%

Lipids/BMI ↓

SBP -9.2%

Lipids, glucose ↓

Blood pressure ↓

Blood flow +1.4%

HDL +7.7%

BP, LDL -6%

Inflammation, fibrinogen -42%

Cardiac events -4.6%

Kidney function +3.2

Lower BP, waist -1.5 cm

Heart strain reduced

↓ lipids, inflammation

↑ HDL, -24% homocysteine

LDL-C down more

TC/HDL-C unchanged

BP ↓; +FMD

+Glucose/waist ↓

HDL↑, SBP↓ 10 mmHg

VAI↓ 0.75

BMI/cholesterol down

HDL up

Blood pressure ↓

Triglycerides ↓ HDL ↑

Triglycerides -14 mg/dL

HbA1c -1.15%

Clot-busting, flow +venous

RBC aggregation, viscosity -

Vascular stiffness, BP

LDL: -8%

Artery plaque, IMT ↓

Inflammation ↓ more than control

Cholesterol/triglycerides -12%

Lipid peroxides -33%

LDL, glucose down

insulin resistance down

Lipids, glucose −23.7%

Inflammation, kidney stability

LAP -8.7; IL-6 rise blunted

Better saliva microbes; heart risk

Autonomic support, +HRV

MIBG preservation, -14% loss

↓Triglycerides −15%

↓LDL, oxidative stress

Triglycerides -15%

LDL/oxidative stress

QTc +28 ms

No QTc change

HDL +0.08 mmol/L

CVD risk -0.8%

vascular age -1.9y

LDL/TC down 9–16%

Post-meal TG down 73%

HDL↑, BP↓

AIx/BP↓